Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Revive Therapeutics Ltd C.RVV

Alternate Symbol(s):  RVVTF

Healthcare
Revive Therapeutics Ltd. is a Canada-based life sciences company. The Company is focused on the research and development of therapeutics and diagnostics for infectious diseases, medical countermeasures, and rare disorders. It is engaged in exploring the use of Bucillamine for the potential treatment of nerve agent exposure and long COVID. The Company, through its diagnostics division, is... see more

Recent & Breaking News (CSE:RVV)

Revive Therapeutics Announces Acceptance of Abstract for Cannabinoid Delivery Technology at 29th International Conference on Polyphenols and the 9th Tannin Conference

GlobeNewswire May 10, 2018

Revive Therapeutics Announces Exclusive License Agreement with Wisconsin Alumni Research Foundation for Cannabinoid Delivery Technology

GlobeNewswire April 30, 2018

Revive Therapeutics Retained Mi3 Communications for Investor Relations Services

GlobeNewswire March 28, 2018

Revive Therapeutics and Ehave Enter Into Patient Research Data Collaboration Agreement for Medical Cannabis Liver Disease Program

GlobeNewswire March 1, 2018

Revive Therapeutics Announces Results for the Three and Six Months Ended December 31, 2017

GlobeNewswire February 27, 2018

Revive Therapeutics Submits Cannabinoid Delivery Technology Findings Abstract for 29th International Conference on Polyphenols and the 9th Tannin Conference

GlobeNewswire January 31, 2018

Revive Therapeutics Advances Research Program of Cannabinoid-Based Therapies Targeting Liver Diseases

GlobeNewswire January 30, 2018

Datametrex Plans to Spin Out Graph Blockchain Joint Venture

GlobeNewswire January 4, 2018

Revive Therapeutics Announces Update on its Collaboration Agreement with Health Canada Licensed Dealer for Medical Cannabis...

MarketWire Canada January 4, 2018

Datametrex JV Graph Blockchain Announces Financing

GlobeNewswire January 3, 2018

Datametrex Graph Blockchain Announces Collaboration Agreement With Revive Therapeutics to Develop a Patient Data Blockchain Platform

GlobeNewswire December 21, 2017

Revive Therapeutics Enters into Collaboration Agreement with Health Canada Licensed Dealer for Medical Cannabis and US FDA Approved Laboratory

Marketwired December 18, 2017

Revive Therapeutics Announces Update on Development of Datametrex Artificial Intelligence Component in Blockchain Enabled Patient-Focused Program for Medical Cannabis Sector

Marketwired December 4, 2017

Revive Therapeutics Announces Results for the Three Months Ended September 30, 2017

MarketWire Canada November 29, 2017

Revive Therapeutics Announces Successful Final Results of Novel Cannabinoid Delivery Technology Unlocking Commercialization Opportunities in the Medical Cannabis and Pharmaceutical Sectors

MarketWire Canada November 29, 2017

Nexalogy Enters into License and Development Agreement with Revive to Develop AI Component in Blockchain Enabled Patient-Focused Program

GlobeNewswire November 27, 2017

Revive Therapeutics Appoints Blockchain Expert, Bernie Doyle, as Technical Advisor to Support Development of Medical Cannabis Patient-Focused Program Enabled by Blockchain and AI Technology

Marketwired November 21, 2017

Revive Therapeutics Ltd. Announces Results for Fiscal Year Ended June 30, 2017

MarketWire Canada October 19, 2017

Revive Therapeutics Announces Positive Results of its Novel Cannabinoid Delivery Technology

MarketWire Canada October 11, 2017

Revive Therapeutics Enters into Research Collaboration with Sanyal Biotechnology for Liver Diseases

Marketwired October 2, 2017